FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WHITE MILES D
2. Issuer Name and Ticker or Trading Symbol

ABBOTT LABORATORIES [ ABT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman and CEO
(Last)          (First)          (Middle)

100 ABBOTT PARK ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

7/25/2016
(Street)

ABBOTT PARK, IL 60064-6400
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value   7/25/2016     M    550000   A $25.2461   2010517   D    
Common shares without par value   7/25/2016     P    3647   A $43.155   2014164   D    
Common shares without par value   7/25/2016     P    13500   A $43.29   2027664   D    
Common shares without par value   7/25/2016     P    20602   A $43.22   2048266   D    
Common shares without par value   7/25/2016     P    7300   A $43.14   2055566   D    
Common shares without par value   7/25/2016     P    300   A $43.065   2055866   D    
Common shares without par value   7/25/2016     P    3800   A $43.24   2059666   D    
Common shares without par value   7/25/2016     P    35664   A $43.08   2095330   D    
Common shares without par value   7/25/2016     P    12600   A $43.19   2107930   D    
Common shares without par value   7/25/2016     P    3220   A $43.145   2111150   D    
Common shares without par value   7/25/2016     P    1800   A $43.185   2112950   D    
Common shares without par value   7/25/2016     P    2100   A $43.16   2115050   D    
Common shares without par value   7/25/2016     P    8700   A $43.15   2123750   D    
Common shares without par value   7/25/2016     P    100   A $43.32   2123850   D    
Common shares without par value   7/25/2016     P    1900   A $43.115   2125750   D    
Common shares without par value   7/25/2016     P    7080   A $43.18   2132830   D    
Common shares without par value   7/25/2016     P    3504   A $43.225   2136334   D    
Common shares without par value   7/25/2016     P    100   A $43.1525   2136434   D    
Common shares without par value   7/25/2016     P    9100   A $43.235   2145534   D    
Common shares without par value   7/25/2016     P    9198   A $43.265   2154732   D    
Common shares without par value   7/25/2016     P    6758   A $43.25   2161490   D    
Common shares without par value   7/25/2016     P    100   A $43.2725   2161590   D    
Common shares without par value   7/25/2016     P    200   A $43.335   2161790   D    
Common shares without par value   7/25/2016     P    10300   A $43.07   2172090   D    
Common shares without par value   7/25/2016     P    25400   A $43.09   2197490   D    
Common shares without par value   7/25/2016     P    6575   A $43.245   2204065   D    
Common shares without par value   7/25/2016     P    14802   A $43.26   2218867   D    
Common shares without par value   7/25/2016     P    23598   A $43.275   2242465   D    
Common shares without par value   7/25/2016     P    10499   A $43.105   2252964   D    
Common shares without par value   7/25/2016     P    100   A $43.1725   2253064   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)   (1) $25.2461   7/25/2016     M         550000    2/16/2010   2/15/2017   Common shares   550000   $25.2461   0   D    

Explanation of Responses:
( 1)  Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:
Form 1 of 5. The transactions reported on this Form 4 are part of a series of transactions pursuant to which Mr. White personally invested $45.5 million in cash to purchase a total of 1,281,500 shares on his own account, increasing his total ownership from 1,460,517 shares to 2,742,017 shares. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WHITE MILES D
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400
X
Chairman and CEO

Signatures
John A. Berry, by power of attorney for Miles D. White 7/27/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.